My thinking on that SPP very similar numbers, S. To be frank its...

First 133 Last

Share
Profile

Follow
Brickwalls

8,883 Posts.

1905

26/04/21

12:49

Post #: 52722302
Share

Originally posted by slura: ↑

I felt very much like you initially but the more I sit back and take in the more I’m ok with this raise. Essentially if the battery announcement was to be held back until Wednesday, then you risk the battery announcement taking away focus from our product launch for the EuGeni RDT.

ADO will have $14m in the bank and then have another $4m more on the way from the SPP. This money will give us a pathway to accelerate our timelines and commercialise our tests. I believe that we will be getting swamped with demand from all over the globe for our Covid tests and in the next 1-6 months will see the contracts rolling in that are incredible.

The raise will be heavily oversubscribed and there will be huge scale backs, these buyers won’t forget the battery announcement when we resume trading on Wednesday. No chance of this falling back to 26c with the media attention that we will get on Wednesday as we launch EuGeni.

The SPP won’t have any influence on the share price as holders will only be able to buy approximately 10-15k shares each or $2600-$3500. Can’t see holders needing to sell to fund that and if they do, I personally would sell something else.

So personally, I think our management could have done better, but it won’t effect us too much.

Expand

My thinking on that SPP very similar numbers, S. To be frank its nice for SPP offer. but pissant numbers required with possible prospect (cost & time) required - they'll bettet off letting SIs scoop the lot IMHO. SIO is nothing to do with company value, but it may offer an opportunity to consolidate.

Last edited by Brickwalls: 26/04/21

ADO Price at posting: 41.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

There are more pages in this discussion • 328 more messages in this thread...

First 133 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $51.83M

Open	High	Low	Value	Volume
2.1¢	2.1¢	2.1¢	$7.317K	348.4K

Buyers (Bids)

No.	Vol.	Price($)
1	127764	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	642809	7

View Market Depth

No.	Vol.	Price($)
1	127764	0.021
18	2477550	0.020
8	2890767	0.019
8	622665	0.018
3	94160	0.017

Price($)	Vol.	No.
0.022	642809	7
0.023	422310	4
0.024	306228	2
0.025	214144	4
0.027	573112	1

Last trade - 15.10pm 17/07/2024 (20 minute delay)

ADO (ASX) Chart

My thinking on that SPP very similar numbers, S. To be frank its...

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

My thinking on that SPP very similar numbers, S. To be frank its...

Top Stories

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News